VES4US
Go to projects

VES4US

Health, Agri-food and Bioeconomy

6

partners

36

months

3 M€

total budget

6

countries

The Ves4us project is a new European initiative funded by the European Commission’s Horizon 2020 Programme, in the Future and Emerging Technologies (FET) category. Its main objective is to generate a wide range of radically new, high-value products in the fields of nutrition, cosmetics and health sciences, based on naturally occurring extracellular vesicles (EVs), which could be used as next-generation vehicles for targeted molecular delivery.

CHALLENGE

The discovery of EVs as natural carriers of small molecules and functional proteins has aroused great interest in the field of drug delivery, as it may be possible to use these vesicles for targeted therapeutic delivery of peptides and drugs. In addition, new technologies, that have not yet been used, will be developed.

SOLUTION

Through this project, a drug delivery system will be developed, based on biocompatible and cost-effective, naturally occurring vesicles, which would improve the bioavailability, efficacy and safety of the loaded bioactive compounds. A high-risk, high-gain technical approach will be proposed to further develop the technological processes inherent to EV isolation and subsequent functionalisation in order to merge them into a highly cooperative frontier research strategy.

RESULTS

The metabolic properties of natural sources of EVs are actively investigated worldwide, based on strategic priorities, with an approach that prioritises natural sources. This project will contribute to national and EU research agendas by expanding the frontiers of biotechnology, translating fundamental work results into market-driven opportunities related to the nanomedicine, cosmetics and nutraceuticals sectors.

This project has received funding from the European Union’s Horizon 2020 Research and Innovation programme, under grant agreement No. 801338.

Laura Sesma

“Ves4us' scientific approach responds to societal and market needs. The worlds of basic science and industry will meet to reach promising results in emerging technologies, biotechnology, nanotechnology and bioscience. ”

Laura Sesma

Senior R&D&I Consultant

Team involved

Consortium

It's not about the sector, it's the about project

The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.

Areas of specialisation

How can we help you?

Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.

Get to know our services
contact